RAD140 (1182367-47-0) video
RAD140 (1182367-47-0) Description
RAD140 also known as Testolone (RAD140),it is a selective androgen receptor modulator (SARM) being developed by the pharmaceutical company Radius for the treatment of breast cancer and muscle wasting in postmenopausal women. Testolone is very new to the commercial market with its initial discovery in 2010.
RAD140 as a nonsteroidal selective androgen receptor modulator (SARM). It stimulates androgen receptors in the bone and the muscle with greater affinity than in the reproductive organs. RAD140 has gained popularity amongst bodybuilders and athletes looking to increase muscle mass.
RAD140 (1182367-47-0) Specifications
|Drug Class||selective androgen receptor modulator (SARM)|
|Molecular Weight||393.831 g/mol|
|Monoisotopic Mass||393.099 g/mol|
|Melting Point||No data available|
|Freezing Point||No data available|
|Biological Half-Life||No data available|
|Solubility||Water Solubility 0.153 mg/mL|
|Storage Temperature||Store at room temperature|
|RAD140 Application||RAD140 is an investigational selective androgen receptor modulator (SARM) for the treatment of conditions such as muscle wasting and breast cancer.|